These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16213066)

  • 1. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects.
    de Bruyn G; Vargas-Cortez M; Warren T; Tyring SK; Fife KH; Lalezari J; Brady RC; Shahmanesh M; Kinghorn G; Beutner KR; Patel R; Drehobl MA; Horner P; Kurtz TO; McDermott S; Wald A; Corey L
    Vaccine; 2006 Feb; 24(7):914-20. PubMed ID: 16213066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.
    Wald A; Zeh J; Selke S; Warren T; Ryncarz AJ; Ashley R; Krieger JN; Corey L
    N Engl J Med; 2000 Mar; 342(12):844-50. PubMed ID: 10727588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P
    Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
    Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
    J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virologic characteristics of subclinical and symptomatic genital herpes infections.
    Wald A; Zeh J; Selke S; Ashley RL; Corey L
    N Engl J Med; 1995 Sep; 333(12):770-5. PubMed ID: 7643884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein-D-adjuvant vaccine to prevent genital herpes.
    Stanberry LR; Spruance SL; Cunningham AL; Bernstein DI; Mindel A; Sacks S; Tyring S; Aoki FY; Slaoui M; Denis M; Vandepapeliere P; Dubin G;
    N Engl J Med; 2002 Nov; 347(21):1652-61. PubMed ID: 12444179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
    Andrews WW; Kimberlin DF; Whitley R; Cliver S; Ramsey PS; Deeter R
    Am J Obstet Gynecol; 2006 Mar; 194(3):774-81. PubMed ID: 16522412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine.
    Bernstein DI; Aoki FY; Tyring SK; Stanberry LR; St-Pierre C; Shafran SD; Leroux-Roels G; Van Herck K; Bollaerts A; Dubin G;
    Clin Infect Dis; 2005 May; 40(9):1271-81. PubMed ID: 15825029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.
    Kim HN; Meier A; Huang ML; Kuntz S; Selke S; Celum C; Corey L; Wald A
    J Infect Dis; 2006 Aug; 194(4):420-7. PubMed ID: 16845624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for herpes simplex virus infections.
    Koelle DM
    Curr Opin Investig Drugs; 2006 Feb; 7(2):136-41. PubMed ID: 16499283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Herpes simplex virus vaccine studies: from past to present].
    Us D
    Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of herpes simplex virus from the genital tract during symptomatic recurrence on the buttocks.
    Kerkering K; Gardella C; Selke S; Krantz E; Corey L; Wald A
    Obstet Gynecol; 2006 Oct; 108(4):947-52. PubMed ID: 17012458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on short-course episodic and prevention therapies for herpes genitalis.
    Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
    Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Holy Grail: immune control of human herpes simplex virus infection and disease.
    Cunningham AL; Mikloska Z
    Herpes; 2001 Mar; 8 Suppl 1():6A-10A. PubMed ID: 11867028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.